- Home
- AKRO vs RUN Comparison
AKRO vs RUN Comparison
Compare AKRO & RUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- RUN
- Stock Information
- Founded
- AKRO 2017
- RUN 2007
- Country
- AKRO United States
- RUN United States
- Employees
- AKRO N/A
- RUN N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- RUN Industrial Machinery/Components
- Sector
- AKRO Health Care
- RUN Miscellaneous
- Exchange
- AKRO Nasdaq
- RUN Nasdaq
- Market Cap
- AKRO 3.9B
- RUN 3.7B
- IPO Year
- AKRO 2019
- RUN 2015
- Fundamental
- Price
- AKRO $45.02
- RUN $18.06
- Analyst Decision
- AKRO Strong Buy
- RUN Buy
- Analyst Count
- AKRO 8
- RUN 20
- Target Price
- AKRO $80.38
- RUN $16.12
- AVG Volume (30 Days)
- AKRO 856.3K
- RUN 18.9M
- Earning Date
- AKRO 08-08-2025
- RUN 08-06-2025
- Dividend Yield
- AKRO N/A
- RUN N/A
- EPS Growth
- AKRO N/A
- RUN N/A
- EPS
- AKRO N/A
- RUN N/A
- Revenue
- AKRO N/A
- RUN $2,129,272,000.00
- Revenue This Year
- AKRO N/A
- RUN $11.84
- Revenue Next Year
- AKRO N/A
- RUN $8.69
- P/E Ratio
- AKRO N/A
- RUN N/A
- Revenue Growth
- AKRO N/A
- RUN 3.27
- 52 Week Low
- AKRO $21.34
- RUN $5.38
- 52 Week High
- AKRO $58.40
- RUN $21.77
- Technical
- Relative Strength Index (RSI)
- AKRO 38.25
- RUN 73.11
- Support Level
- AKRO $43.08
- RUN $14.95
- Resistance Level
- AKRO $46.18
- RUN $16.51
- Average True Range (ATR)
- AKRO 1.62
- RUN 1.05
- MACD
- AKRO -0.30
- RUN 0.10
- Stochastic Oscillator
- AKRO 29.56
- RUN 98.50
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About RUN Sunrun Inc.
Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.